Citadel Advisors’s Blonder Tongue Laboratories Inc BDR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q2 | – | Sell |
-21,950
| Closed | -$14K | – | 14799 |
|
|
2022
Q1 | $14K | Buy |
+21,950
| New | +$11.8K | ﹤0.01% | 13341 |
|
|
2021
Q3 | – | Sell |
-56,871
| Closed | -$75K | – | 15141 |
|
|
2021
Q2 | $75K | Sell |
56,871
-31,028
| -35% | -$38.1K | ﹤0.01% | 13120 |
|
|
2021
Q1 | $129K | Buy |
87,899
+75,853
| +630% | +$119K | ﹤0.01% | 12218 |
|
|
2020
Q4 | $16K | Sell |
12,046
-23,888
| -66% | -$28.2K | ﹤0.01% | 10806 |
|
|
2020
Q3 | $29K | Buy |
+35,934
| New | +$29.4K | ﹤0.01% | 9779 |
|
|
2019
Q3 | – | Sell |
-17,394
| Closed | -$17K | – | 9983 |
|
|
2019
Q2 | $17K | Sell |
17,394
-14,460
| -45% | -$14.2K | ﹤0.01% | 8970 |
|
|
2019
Q1 | $35K | Buy |
+31,854
| New | +$36.1K | ﹤0.01% | 8954 |
|
|
2018
Q2 | – | Sell |
-16,405
| Closed | -$12K | – | 9457 |
|
|
2018
Q1 | $12K | Sell |
16,405
-23,413
| -59% | -$15K | ﹤0.01% | 8170 |
|
|
2017
Q4 | $24K | Buy |
+39,818
| New | +$19.1K | ﹤0.01% | 7806 |
|
|
2017
Q2 | – | Sell |
-29,823
| Closed | -$17K | – | 8277 |
|
|
2017
Q1 | $17K | Buy |
+29,823
| New | +$20.1K | ﹤0.01% | 7297 |
|
|
2016
Q4 | – | Sell |
-33,230
| Closed | -$20K | – | 8059 |
|
|
2016
Q3 | $20K | Sell |
33,230
-4,110
| -11% | -$2.37K | ﹤0.01% | 7053 |
|
|
2016
Q2 | $18K | Buy |
37,340
+4,171
| +13% | +$1.7K | ﹤0.01% | 6655 |
|
|
2016
Q1 | $13K | Buy |
+33,169
| New | +$13.5K | ﹤0.01% | 6571 |
|
|
2015
Q3 | – | Sell |
-20,724
| Closed | -$16K | – | 9359 |
|
|
2015
Q2 | $16K | Buy |
20,724
+10,405
| +101% | +$8.2K | ﹤0.01% | 8268 |
|
|
2015
Q1 | $10K | Buy |
+10,319
| New | +$19K | ﹤0.01% | 8194 |
|
|
2014
Q4 | – | Sell |
-11,740
| Closed | -$15K | – | 8822 |
|
|
2014
Q3 | $15K | Sell |
11,740
-3,463
| -23% | -$4.42K | ﹤0.01% | 7628 |
|
|
2014
Q2 | $14K | Sell |
15,203
-2,767
| -15% | -$2.55K | ﹤0.01% | 7470 |
|
|
2014
Q1 | $16K | Sell |
17,970
-2,141
| -11% | -$2.07K | ﹤0.01% | 7375 |
|
|
2013
Q4 | $20K | Buy |
+20,111
| New | +$19.1K | ﹤0.01% | 6464 |
|
Citadel Advisors's BDR Position: Q2 2022 in Review
Citadel Advisors sold out of Blonder Tongue Laboratories Inc (BDR) in Q2 2022, closing a stake of 21,950 shares — an estimated $14K sold.
Citadel Advisors first reported a position in BDR in Q4 2013 and held it in 19 quarters. The position peaked at $129K in Q1 2021. 0 funds tracked by Wall St. Rank hold BDR as of Q2 2022.
- Citadel Advisors reported no remaining Blonder Tongue Laboratories Inc position as of Q2 2022 after selling out during the quarter.
- Citadel Advisors sold 21,950 Blonder Tongue Laboratories Inc shares in Q2 2022, an estimated $14K.
- Citadel Advisors first reported a position in Blonder Tongue Laboratories Inc in Q4 2013 and held it in 19 quarters.
- Citadel Advisors's Blonder Tongue Laboratories Inc position peaked at $129K in Q1 2021.
- 0 funds tracked by Wall St. Rank held Blonder Tongue Laboratories Inc as of Q2 2022.
Based on Citadel Advisors's 13F filing for Q2 2022, filed 15 Aug 2022.